214 related articles for article (PubMed ID: 32276795)
61. [Prevalence of chronic hepatitis B virus (HBV) infection in closed communities and risk behaviour].
Nazare C; Gîrleanu I; Cojocariu-Salloum C; Trifan A
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):325-30. PubMed ID: 21870718
[TBL] [Abstract][Full Text] [Related]
62. Prevalence and factors associated with alcohol and drug-related disorders in prison: a French national study.
Lukasiewicz M; Falissard B; Michel L; Neveu X; Reynaud M; Gasquet I
Subst Abuse Treat Prev Policy; 2007 Jan; 2():1. PubMed ID: 17204156
[TBL] [Abstract][Full Text] [Related]
63. Prevalence and correlates of in-prison substance use among incarcerated women in Spain.
Sánchez FC; Fearn N; Vaughn MG
J Ethn Subst Abuse; 2018; 17(3):356-374. PubMed ID: 28166472
[TBL] [Abstract][Full Text] [Related]
64. Surveillance of HIV infection and related risk behaviour in European prisons. A multicentre pilot study.
Rotily M; Weilandt C; Bird SM; Käll K; Van Haastrecht HJ; Iandolo E; Rousseau S
Eur J Public Health; 2001 Sep; 11(3):243-50. PubMed ID: 11582600
[TBL] [Abstract][Full Text] [Related]
65. Harm reduction measures and injecting inside prison versus mandatory drugs testing: results of a cross sectional anonymous questionnaire survey. The European Commission Network on HIV Infection and Hepatitis in Prison.
Bird AG; Gore SM; Hutchinson SJ; Lewis SC; Cameron S; Burns S
BMJ; 1997 Jul; 315(7099):21-4. PubMed ID: 9233321
[TBL] [Abstract][Full Text] [Related]
66. Piercing among adolescents: body art as risk marker.
Suris JC; Jeannin A; Chossis I; Michaud PA
J Fam Pract; 2007 Feb; 56(2):126-30. PubMed ID: 17270119
[No Abstract] [Full Text] [Related]
67. Penile implants among prisoners-a cause for concern?
Yap L; Butler T; Richters J; Malacova E; Wand H; Smith AM; Grant L; Richards A; Donovan B
PLoS One; 2013; 8(1):e53065. PubMed ID: 23326383
[TBL] [Abstract][Full Text] [Related]
68. Prevalence of tuberculosis, HIV/AIDS, and hepatitis; in a prison of Balochistan: a cross-sectional survey.
Wali A; Khan D; Safdar N; Shawani Z; Fatima R; Yaqoob A; Qadir A; Ahmed S; Rashid H; Ahmed B; Khan S
BMC Public Health; 2019 Dec; 19(1):1631. PubMed ID: 31801496
[TBL] [Abstract][Full Text] [Related]
69. [Characteristics of hepatitis C virus (HCV) infection in closed communities].
Nazare C; Girleanu I; Cojocariu-Salloum C; Trifan A
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):736-41. PubMed ID: 22046780
[TBL] [Abstract][Full Text] [Related]
70. High rates of drug use, but low rates of HIV risk behaviours among injecting drug users during incarceration in Dutch prisons.
van Haastrecht HJ; Bax JS; van den Hoek AA
Addiction; 1998 Sep; 93(9):1417-25. PubMed ID: 9926547
[TBL] [Abstract][Full Text] [Related]
71. Prevalence of Hepatitis B and Hepatitis C Infections among Incarcerated Individuals in Iran: A Cross-Sectional National Bio-behavioral Study in 2019.
Moradi G; Alavian SM; Gholami F; Ramezani R; Ahangarzadeh L; Moradi Y; Sharafi H
Pathogens; 2021 Nov; 10(11):. PubMed ID: 34832678
[No Abstract] [Full Text] [Related]
72. Drug and alcohol use and treatment for Australian Indigenous and non-Indigenous prisoners: demand reduction strategies.
Dolan K; Rodas A; Bode A
Int J Prison Health; 2015; 11(1):30-8. PubMed ID: 25751705
[TBL] [Abstract][Full Text] [Related]
73. Sexual and reproductive history of female prisoners in Iran: a health care needs analysis.
Farhoudi B; Shahmohamadi E; SeyedAlinaghi S; Rostam Afshar Z; Mirzapour P; Nadji S; Golsoorat Pahlaviani F; Tashakorian M; Hackett D
Int J Prison Health; 2023 May; ():. PubMed ID: 37143342
[TBL] [Abstract][Full Text] [Related]
74. Assessment of cardiovascular disease risk factors and diabetes mellitus in Australian prisons: is the prisoner population unhealthier than the rest of the Australian population?
D'Souza RM; Butler T; Petrovsky N
Aust N Z J Public Health; 2005 Aug; 29(4):318-23. PubMed ID: 16222927
[TBL] [Abstract][Full Text] [Related]
75. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway.
Holsen DS; Harthug S; Myrmel H
Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):673-6. PubMed ID: 7694850
[TBL] [Abstract][Full Text] [Related]
76. Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice.
Culbert GJ; Waluyo A; Iriyanti M; Muchransyah AP; Kamarulzaman A; Altice FL
Drug Alcohol Depend; 2015 Apr; 149():71-9. PubMed ID: 25659895
[TBL] [Abstract][Full Text] [Related]
77. Hepatitis C transmission through tattooing: a case report.
Thompson SC; Hernberger F; Wale E; Crofts N
Aust N Z J Public Health; 1996 Jun; 20(3):317-8. PubMed ID: 8768424
[TBL] [Abstract][Full Text] [Related]
78. Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis.
Vescio MF; Longo B; Babudieri S; Starnini G; Carbonara S; Rezza G; Monarca R
J Epidemiol Community Health; 2008 Apr; 62(4):305-13. PubMed ID: 18339822
[TBL] [Abstract][Full Text] [Related]
79. Knowledge of potential risk of blood-borne viral infections and tattooing practice among adults in Mandalay Region, Myanmar.
Show KL; Le Win L; Saw S; Myint CK; Than KM; Oo YTN; Wai KT
PLoS One; 2019; 14(1):e0209853. PubMed ID: 30629615
[TBL] [Abstract][Full Text] [Related]
80. Hepatitis B and Hepatitis C in prisons: a prevalence study.
Kose S; Adar P; Gozaydin A; Kuzucu L; Akkoclu G
Int J Prison Health; 2019 Jun; 15(2):162-167. PubMed ID: 31172859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
